Skip to main content
. 2019 Dec 17;6:281. doi: 10.3389/fmed.2019.00281

Figure 2.

Figure 2

NiDaR prolongs life after hemorrhagic shock. Mean survival time (minutes) following HI and treatment in each of the experimental groups (mean ± SEM); n = 5–6 in each group, *indicates p < 0.05 compared to HI + Veh. NiDaR (2 mg/Kg of each constituent) was administered immediately following shock period.